Whole Exome Sequencing Market - Top Companies and Manufacturers

Companies Dominating the Whole Exome Sequencing Landscape

Illumina, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Bio-Rad Laboratories Inc.
Ambry Genetics
Eurofins Discovery
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies Inc.
BGI Group
Macrogen Inc.
Azenta US Inc.

Browse Key Market Insights with Data Illustration:

Whole Exome Sequencing Market Size & Share | Growth Trends 2037

In the News

The first blood virological profile of the Chinese population was created in October 2022 by BGI Group, Ruijin Hospital, and Shanghai Jiao Tong University Institute of Translational Medicine using BGI's DNBSEQ sequencing platform. This analysis involved a thorough examination of non-human genetic sequences in the whole genome sequencing (WGS) data of about 10,584 individuals from the China Metabolic Analysis Program (ChinaMAP). The findings, which were published in the journal Cell Discovery, serve as a resource for viral infection epidemiology and prevention.
The SEQuoia RiboDepletion Kit, which increases test efficiency by removing pointless ribosomal RNA (rRNA) fragments from an RNA-Seq library, has been introduced by Bio-Rad Laboratories, Inc., a world leader in life science research and clinical diagnostic products.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of whole exome sequencing is estimated at USD 5.54 billion.

The whole exome sequencing market size was over USD 4.62 billion in 2024 and is anticipated to cross USD 83.17 billion by 2037, witnessing more than 24.9% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by growing prevalence of rare disease, an increase in funding for genomics research, reduction in cost of sequencing, and others.

North America industry is predicted to account for largest revenue share of 39% by 2037, backed by growing prevalence of hereditary and chronic disease, along with surge in demand for targeted and precision medicine in the region.

The major players in the market include Illumina, Inc., Bio-Rad Laboratories Inc., Ambry Genetics, Eurofins Discovery, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., BGI Group, Macrogen Inc., Azenta US Inc.

Whole Exome Sequencing Market - Top Companies and Manufacturers

Companies Dominating the Whole Exome Sequencing Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the whole exome sequencing market?

Why is the whole exome sequencing sector gaining traction in near future?

Which region accounted for the largest whole exome sequencing industry share?

Who are the major whole exome sequencing players?